{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:05:55Z","timestamp":1792757155804,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.phrs.2017.05.013","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T20:45:17Z","timestamp":1495226717000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":717,"special_numbering":"C","title":["Obesity and hypertension"],"prefix":"10.1016","volume":"122","author":[{"given":"Gino","family":"Seravalle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2017.05.013_bib0005","series-title":"Obesity","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.phrs.2017.05.013_bib0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/jama.2009.2012","article-title":"Prevalence of high body mass index in US children and adolescents, 2007\u20132008","volume":"303","author":"Ogden","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2017.05.013_bib0015","first-page":"766","article-title":"Global, regional, national prevalence of overweight and obesity in children and adults 1980\u20132013: a systematic analysis","volume":"384","author":"Gakidou","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.05.013_bib0020","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1210\/jc.2008-1356","article-title":"Epidemiology of obesity in the Western Hemisphere","volume":"93","author":"Ford","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2017.05.013_bib0025","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archinte.162.16.1867","article-title":"Overweight and obesity as determinants of cardiovascular risk: the Framingham experience","volume":"162","author":"Wilson","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.phrs.2017.05.013_bib0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7326\/0003-4819-138-1-200301070-00008","article-title":"Obesity in adulthood and its consequences for life expectancy: a life-table analysis","volume":"138","author":"Peeters","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2017.05.013_bib0035","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/archinte.164.19.2126","article-title":"The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee guidelines","volume":"164","author":"Wang","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.phrs.2017.05.013_bib0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/oby.20181","article-title":"Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment \u2212a position paper of the Obesity Society and the American Society of Hypertension","volume":"21","author":"Landsberg","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.phrs.2017.05.013_bib0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/oby.2002.64","article-title":"A genealogical study of essential hypertension with and without obesity in French Canadians","volume":"10","author":"Pausova","year":"2002","journal-title":"Obes. Res."},{"key":"10.1016\/j.phrs.2017.05.013_bib0050","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/430133","article-title":"Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension","volume":"76","author":"Hamet","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.phrs.2017.05.013_bib0055","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1210\/jc.2008-1585","article-title":"Role of body fat distribution and the metabolic complications of obesity","volume":"93","author":"Jensen","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2017.05.013_bib0060","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.HYP.25.4.560","article-title":"Sympathetic activation in obese normotensive subjects","volume":"25","author":"Grassi","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0065","first-page":"175","article-title":"Sympathetic nervous system, hypertension, obesity, and metabolic syndrome. High Blood Press","volume":"23","author":"Seravalle","year":"2016","journal-title":"Cardiovasc. Prev."},{"key":"10.1016\/j.phrs.2017.05.013_bib0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MED.0b013e3282be90a8","article-title":"Endothelial dysfunction in obesity: etiological role in atherosclerosis","volume":"14","author":"Meyers","year":"2007","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.phrs.2017.05.013_bib0075","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fphys.2012.00284","article-title":"Sympathetic regulaiton of vascular function in health and disease","volume":"3","author":"Bruno","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2017.05.013_bib0080","first-page":"959","article-title":"Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980","volume":"16","author":"Young","year":"1992","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.phrs.2017.05.013_bib0085","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1161\/01.CIR.96.10.3423","article-title":"Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects","volume":"96","author":"Vaz","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.013_bib0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.HYP.36.4.538","article-title":"reflex abnormalities in obesity-related hypertension","volume":"36","author":"Grassi","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0095","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/00004872-200412000-00019","article-title":"Effects of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensive","volume":"22","author":"Grassi","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0100","first-page":"H414","article-title":"Subcutaneous obesity is not associated with sympathetic neural activation","volume":"287","author":"Alvarez","year":"2004","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.phrs.2017.05.013_bib0105","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1097\/00004872-200411000-00007","article-title":"Fat distribution, body mass index and blood pressure in 22090 men and women in the Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk)study","volume":"22","author":"Canoy","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.HYP.16.5.484","article-title":"Close correlation of intra-abdominal fat accumulation to hypertension in obese women","volume":"16","author":"Kanai","year":"1990","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.HYP.0000137982.10191.0a","article-title":"Visceral fat in hypertension: influence on insulin resistance and B-cell function","volume":"44","author":"Sironi","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0120","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00125-005-1798-z","article-title":"Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome","volume":"48","author":"Grassi","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2017.05.013_bib0125","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.CIR.99.9.1183","article-title":"Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea","volume":"99","author":"Narkiewicz","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.013_bib0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.HYP.0000174243.39897.6c","article-title":"Obstructive sleep apnea-dependent and \u2212independent adrenergic activation in obesity","volume":"46","author":"Grassi","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.1999.tb07788.x","article-title":"Mechanisms of hypertension and kidney disease in obesity","volume":"892","author":"Hall","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2017.05.013_bib0140","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/07435809809032689","article-title":"Aldosterone in obesity","volume":"24","author":"Goodfriend","year":"1998","journal-title":"Endocr. Res."},{"key":"10.1016\/j.phrs.2017.05.013_bib0145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.semnephrol.2007.07.009","article-title":"The association of aldosterone with obesity-related hypertension and the metabolic syndrome","volume":"27","author":"Bochud","year":"2007","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.phrs.2017.05.013_bib0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-2008-1065336","article-title":"New mechanisms to control aldosterone synthesis","volume":"40","author":"Willenberg","year":"2008","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.phrs.2017.05.013_bib0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.HYP.0000132568.71409.a2","article-title":"Is there a rationale for angiotensin blockade in the management of obesity hypertension","volume":"44","author":"Sharma","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.HYP.0000151325.83008.b4","article-title":"Obesity-associated hypertension: new insights into mechanisms","volume":"45","author":"Rahmuni","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0165","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/00004872-200309000-00027","article-title":"Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study","volume":"21","author":"Grassi","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0170","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.113.02988","article-title":"Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients","volume":"64","author":"Seravalle","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI17845","article-title":"Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice","volume":"112","author":"Masuzaki","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2017.05.013_bib0180","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/hy1201.096117","article-title":"Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity","volume":"38","author":"Grassi","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004872-200502000-00001","article-title":"Endothelial function and dysfunction: part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension","volume":"23","author":"Brunner","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0190","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/01.CIR.97.22.2222","article-title":"Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension","volume":"97","author":"Taddei","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.013_bib0195","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1161\/CIRCULATIONAHA.105.554360","article-title":"Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity","volume":"112","author":"Boudina","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.013_bib0200","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.2337\/diabetes.54.12.3496","article-title":"Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels","volume":"54","author":"Murray","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2017.05.013_bib0205","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jacc.2008.12.050","article-title":"Major role for hypoxia inducible factor-1 and endothelin system in promoting myocardial infarction and hypertension in animal model of obstructive sleep apnea","volume":"53","author":"Belaidi","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.05.013_bib0210","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00125-006-0229-0","article-title":"Cardiac contractile dysfunction in Lep\/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch","volume":"49","author":"Li","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2017.05.013_bib0215","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1210\/jc.2008-1613","article-title":"Adipocytokines and the metabolic complications of obesity","volume":"93","author":"Rasouli","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2017.05.013_bib0220","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2008-1280","article-title":"High-circulating leptin levels are associated with greater risk of hypertension in men independently of body mass and insulin resistance: results of an eight-year follow-up study","volume":"93","author":"Galletti","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2017.05.013_bib0225","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ajh.2009.244","article-title":"Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study","volume":"23","author":"Asferg","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0230","first-page":"R566","article-title":"Selective leptin resistance revisited","volume":"305","author":"Mark","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2017.05.013_bib0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MNH.0b013e3283366cd0","article-title":"Adipokines and blood pressure control","volume":"19","author":"Yiannikouris","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0240","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting Lecture Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2017.05.013_bib0245","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI116542","article-title":"Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans","volume":"92","author":"Vollenweider","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2017.05.013_bib0250","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/08037059409102293","article-title":"The effects of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men","volume":"3","author":"Gudbjorndottir","year":"1994","journal-title":"Blood Press."},{"issue":"6","key":"10.1016\/j.phrs.2017.05.013_bib0255","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.117.09081","article-title":"Serum uric acid and cardiometabolic disease.Another brick in the wall?","volume":"69","author":"Borghi","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0260","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S0026-0495(97)90210-9","article-title":"Close correlation between visceral fat accumulation and uric acid metabolism in healthy men","volume":"46","author":"Takahashi","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2017.05.013_bib0265","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.HYP.0000248752.08807.4c","article-title":"Uric acid and the development of hypertension: the Normative Aging Study","volume":"48","author":"Perlstein","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0270","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1210\/jc.2003-031619","article-title":"Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study","volume":"89","author":"Ferreira","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2017.05.013_bib0275","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/CIRCULATIONAHA.107.763730","article-title":"Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus","volume":"118","author":"Levy","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.013_bib0280","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/eurheartj\/ehl254","article-title":"Expert consensus document on arterial stiffness: methodological issues and clinical applications","volume":"27","author":"Laurent","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.05.013_bib0285","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.HYP.26.6.984","article-title":"Radial artery compliance in young obese, normotensive subjects","volume":"26","author":"Mangoni","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0290","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/01.CIR.0000095031.51492.C5","article-title":"Agabiti Rosei E. Prognostic significance of small-artery structure in hypertension","volume":"108","author":"Rizzoni","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.013_bib0295","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/HJH.0b013e32805bf8ed","article-title":"Small artery structure is an independent predictor of cardiovascular events in essential hypertension","volume":"25","author":"Mathiassen","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0300","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/HJH.0000000000000322","article-title":"Evaluation of microvascular structure in humans: a state of the art document of the Working Group on Macrovascular and Microvascular Alterations of the Italian Society of Arterial Hypertension","volume":"32","author":"Virdis","year":"2014","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0305","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1167\/iovs.04-0069","article-title":"Association between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study","volume":"45","author":"Wong","year":"2004","journal-title":"Invest. Ophtalmol. Vis. Sci."},{"key":"10.1016\/j.phrs.2017.05.013_bib0310","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bmj.38124.682523.55","article-title":"Prospective cohort study of retinal vessel diameters and risk of hypertension","volume":"329","author":"Wong","year":"2004","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.phrs.2017.05.013_bib0315","doi-asserted-by":"crossref","first-page":"e52708","DOI":"10.1371\/journal.pone.0052708","article-title":"Czernichow S, for the META-EYE Study Group. Obesity and the microvasculature: a systematic review and meta-analysis","volume":"8","author":"Boillot","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.05.013_bib0320","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/oby.2009.195","article-title":"Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity","volume":"18","author":"Grassi","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/j.phrs.2017.05.013_bib0325","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.2174\/1381612811319130005","article-title":"Structural alterations of the retinal microcirculation in the prehypertensive high- normal blood pressure state","volume":"19","author":"Grassi","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2017.05.013_bib0330","first-page":"105","article-title":"Small artery remodeling and significance in the development of hypertension","volume":"17","author":"Mulvany","year":"2002","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.phrs.2017.05.013_bib0335","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.amjhyper.2004.05.023","article-title":"Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment","volume":"17","author":"Schiffrin","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0340","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/HJH.0b013e328122d9af","article-title":"Predicting hypertension complications from small artery structure","volume":"25","author":"Heagerty","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0345","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","volume":"113","author":"Poirier","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.05.013_bib0350","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.jacc.2004.09.012","article-title":"True uncomplicated obesity is not related to increased left ventricular mass and systolic dysfunction","volume":"44","author":"Iacobellis","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.05.013_bib0355","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/HJH.0b013e328364fb58","article-title":"Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic study","volume":"32","author":"Cuspidi","year":"2014","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0360","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physrev.00017.2007","article-title":"Sweeney G. cardia remodeling in obesity","volume":"88","author":"Abel","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2017.05.013_bib0365","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/HJH.0000000000000882","article-title":"Prevalence and prognosis of ECG abnormalities in normotensive and hypertensive individuals","volume":"34","author":"Lehtonen","year":"2016","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0370","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/HJH.0000000000001121","article-title":"Obesity and ECG left ventricular hypertrophy","volume":"35","author":"Muiesan","year":"2017","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0375","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/HJH.0b013e3283537347","article-title":"Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension","volume":"30","author":"Jordan","year":"2012","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0380","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.05.013_bib0385","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1467-789X.2003.00083.x","article-title":"Treatment of obesity: an update on anti-obesity medications","volume":"4","author":"Halpern","year":"2003","journal-title":"Obes. Rev."},{"key":"10.1016\/j.phrs.2017.05.013_bib0390","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/00004872-200211000-00026","article-title":"Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension","volume":"20","author":"Bakris","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.05.013_bib0395","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa050156","article-title":"Randomized trial of lifestyle modification and pharmacotherapy for obesity","volume":"353","author":"Wadden","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.05.013_bib0400","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.clpt.2006.02.002","article-title":"Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects","volume":"79","author":"Heusser","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2017.05.013_bib0405","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.05.013_bib0410","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ijo.2011.158","article-title":"NN8022-1807 Investigators. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide","volume":"36","author":"Astrup","year":"2012","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.phrs.2017.05.013_bib0415","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sjostrom","year":"2012","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1016\/j.phrs.2017.07.018","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000}}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817304620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817304620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:53:14Z","timestamp":1760910794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817304620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":83,"alternative-id":["S1043661817304620"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.05.013","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity and hypertension","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}